Chemoinformaics analysis of 2-Hydroxyhexadecanoic acid
Molecular Weight | 272.429 | nRot | 14 |
Heavy Atom Molecular Weight | 240.173 | nRig | 1 |
Exact Molecular Weight | 272.235 | nRing | 0 |
Solubility: LogS | -3.159 | nHRing | 0 |
Solubility: LogP | 4.884 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 50.4634 |
nHD | 2 | BPOL | 32.9706 |
QED | 0.372 |
Synth | 2.195 |
Natural Product Likeliness | 0.341 |
NR-PPAR-gamma | 0.274 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.014 |
Pgp-sub | 0.152 |
HIA | 0.023 |
CACO-2 | -4.73 |
MDCK | 0.0000246 |
BBB | 0.956 |
PPB | 0.974461 |
VDSS | 0.907 |
FU | 0.0184866 |
CYP1A2-inh | 0.159 |
CYP1A2-sub | 0.204 |
CYP2c19-inh | 0.275 |
CYP2c19-sub | 0.063 |
CYP2c9-inh | 0.295 |
CYP2c9-sub | 0.957 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.07 |
CYP3a4-inh | 0.063 |
CYP3a4-sub | 0.034 |
CL | 5.968 |
T12 | 0.843 |
hERG | 0.017 |
Ames | 0.05 |
ROA | 0.047 |
SkinSen | 0.887 |
Carcinogencity | 0.239 |
EI | 0.972 |
Respiratory | 0.901 |
NR-Aromatase | 0.131 |
Antiviral | Yes |
Prediction | 0.683068 |